RIPK1 and cancer: RIPK1 is implicated in a broad range of human diseases [43,44,46], and there is significant interest in development of therapeutics to target RIPK1 kinase activity in a variety of human inflammatory diseases, neurodegenerative conditions, and cancer metastasis [46–48].